FDA posed a sprawling set of questions for two-day gene therapy hearing. Here’s what companies and experts will be watching for

Gene therapy is having a moment. Once confined to academic labs and a couple of companies, the field now encompasses hundreds of trials, dozens of companies and billions of investment dollars.

With greater power, though, comes greater responsibility. The FDA is asking a panel of outside experts to try and...

Click to view original post